Literature DB >> 28979534

Infusion medication concentrations in UK's critical care areas: Are the Intensive Care Society's recommendations being used?

Yovita D Titiesari1, Greg Barton2,3, Mark Borthwick4, Susan Keeling5, Peter Keeling6.   

Abstract

Following two studies done in 2007 and 2009, a follow-up of the adherence to the suggested guidelines on drug standardisation has been performed with a suggestion for future standards that can be achieved, to complement the recently published Carter report. The Intensive Care Society (ICS) introduced recommendations for infusion concentrations of 16 medications commonly used in critical care areas. The importance being improvement in patient safety and rationalised use of available critical care resources. Five years after publication of these recommendations, a further audit has been undertaken to assess the level of acceptance and application. This revealed that 89.5% of the 133 surveyed units (representing 42.49% critical care units across the UK) have adopted the recommendations. There are further medication concentrations which could also be standardised.

Entities:  

Keywords:  Medication errors; medication systems; medication therapy management

Year:  2017        PMID: 28979534      PMCID: PMC5606355          DOI: 10.1177/1751143716662664

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  7 in total

1.  Systematic evaluation of errors occurring during the preparation of intravenous medication.

Authors:  Christopher S Parshuram; Teresa To; Winnie Seto; Angela Trope; Gideon Koren; Andreas Laupacis
Journal:  CMAJ       Date:  2008-01-01       Impact factor: 8.262

2.  Costs of intravenous adverse drug events in academic and nonacademic intensive care units.

Authors:  Teryl K Nuckols; Susan M Paddock; Anthony G Bower; Jeffrey M Rothschild; Rollin J Fairbanks; Beverly Carlson; Robert J Panzer; Lee H Hilborne
Journal:  Med Care       Date:  2008-01       Impact factor: 2.983

3.  Do centrally pre-prepared solutions achieve more reliable drug concentrations than solutions prepared on the ward?

Authors:  Carola Dehmel; Stephan A Braune; Georg Kreymann; Michael Baehr; Claudia Langebrake; Heike Hilgarth; Axel Nierhaus; Dorothee C Dartsch; Stefan Kluge
Journal:  Intensive Care Med       Date:  2011-04-30       Impact factor: 17.440

4.  An analysis of patient safety incidents associated with medications reported from critical care units in the North West of England between 2009 and 2012.

Authors:  A N Thomas; R J Taylor
Journal:  Anaesthesia       Date:  2014-05-08       Impact factor: 6.955

5.  Variability in the concentrations of intravenous drug infusions prepared in a critical care unit.

Authors:  Daniel Wren Wheeler; Beverley Ann Degnan; Jobanpreet Singh Sehmi; Rowan Margaret Burnstein; David Krishna Menon; Arun Kumar Gupta
Journal:  Intensive Care Med       Date:  2008-04-22       Impact factor: 17.440

6.  Medication errors involving continuously infused medications in a surgical intensive care unit.

Authors:  Peter M Herout; Brian L Erstad
Journal:  Crit Care Med       Date:  2004-02       Impact factor: 7.598

7.  Discrepancies between ordered and delivered concentrations of opiate infusions in critical care.

Authors:  Christopher S Parshuram; Geraldine Y T Ng; Tommy K L Ho; Julia Klein; Aideen M Moore; Desmond Bohn; Gideon Koren
Journal:  Crit Care Med       Date:  2003-10       Impact factor: 7.598

  7 in total
  2 in total

1.  [Standardized concentrations for continuous infusion-results of a nationwide survey in German intensive care units].

Authors:  Lutz Kreysing; Christian Waydhas; Karl Peter Ittner; Sebastian Schubert; Irene Krämer
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-07-15       Impact factor: 1.552

2.  Analysis of standard concentrations of continuous infusions in nine Spanish neonatal intensive care units.

Authors:  Amaya De Basagoiti; Xabier Antón; Amaya Calleja; Monike De Miguel; Eneritz Guerra; Begoña Loureiro; Ainara Campino
Journal:  Eur J Hosp Pharm       Date:  2020-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.